Trials / Unknown
UnknownNCT05604573
DNA Mutation Detection in Circulating Tumor DNA and Tissue by mmADPS for Pancreatic Cancer
DNA Mutation Detection in Circulating Tumor DNA and Tissue by Massive Multiplex Allele Discrimination Priming System(mmADPS) for Pancreatic Cancer
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 150 (estimated)
- Sponsor
- Seoul National University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
Based on the cell free nucleic acid analysis information of blood samples and genetic mutation profile of EUS-FNB tissue from pancreatic cancer, the concordance between them is evaluated. And based on this information, biomarkers for diagnosis, treatment, and prognosis of pancreatic cancer are explored.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIAGNOSTIC_TEST | cell free DNA in blood, genetic mutation in tissue | Diagnostic test for cell free DNA in blood, genetic mutation in tissue |
Timeline
- Start date
- 2022-02-09
- Primary completion
- 2024-12-31
- Completion
- 2024-12-31
- First posted
- 2022-11-03
- Last updated
- 2022-11-03
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05604573. Inclusion in this directory is not an endorsement.